317 results match your criteria: "Centre Hospitalier Annecy-Genevois[Affiliation]"

Machine learning-based scoring system to predict in-hospital outcomes in patients hospitalized with COVID-19.

Arch Cardiovasc Dis

December 2022

Université de Paris, PARCC, INSERM, 75015 Paris, France; Hôpital Européen Georges-Pompidou, Université de Paris, 75015 Paris, France.

Background: The evolution of patients hospitalized with coronavirus disease 2019 (COVID-19) is still hard to predict, even after several months of dealing with the pandemic.

Aims: To develop and validate a score to predict outcomes in patients hospitalized with COVID-19.

Methods: All consecutive adults hospitalized for COVID-19 from February to April 2020 were included in a nationwide observational study.

View Article and Find Full Text PDF

Background: Given the rapidly evolving pandemic of COVID-19 in 2020, authorities focused on the repurposing of available drugs to develop timely and cost-effective therapeutic strategies. Evidence suggested the potential utility of remdesivir in the framework of an early access program. REMDECO-19 is a multicenter national cohort study assessing the ability of remdesivir to improve the outcome of patients hospitalized with COVID-19.

View Article and Find Full Text PDF

Background and aims: Pancreatic cancer is highly lethal and often diagnosed at an advanced stage. This cohort study analyzes the impact of care pathways, delays, and socio-spatial determinants on pancreatic cancer patients’ diagnosis, treatment, and prognosis. Method: Patients with pancreatic adenocarcinoma newly diagnosed at all stages between January and June 2016 in the AuRA French region were included.

View Article and Find Full Text PDF

Objective: To assess the educational and clinical impact of a tiny baby intubation team (TBIT).

Study Design: Retrospective study comparing endotracheal intubation (ETI) performed: pre-implementation of a TBIT (T1), 6 months post-implementation (T2), and 4 years post-implementation (T3).

Results: Post-implementation (T2), first-attempt success rate in tiny babies increased (44% T1; 59% T2, p = 0.

View Article and Find Full Text PDF

Staphylococcus lugdunensis prosthetic joint infection: A multicentric cohort study.

J Infect

December 2022

Centre de référence pour la prise en charge des infections ostéo-articulaires complexes (CRIOAc Lyon, www.crioac-lyon.fr), Hospices Civils de Lyon, Lyon, France; CIRI - Centre International de Recherche en Infectiologie, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, Ecole Normale Supérieure de Lyon, Univ Lyon, F-69007, Lyon, France; Service des maladies infectieuses et tropicales, Hospices Civils de Lyon, Lyon, France. Electronic address:

Objectives: To describe Staphylococcus lugdunensis prosthetic joint infection (PJI) management and outcome.

Methods: Adults with proven S. lugdunensis PJI were included in a multicentric retrospective cohort.

View Article and Find Full Text PDF

Coadministration of seasonal influenza and COVID-19 vaccines: A systematic review of clinical studies.

Hum Vaccin Immunother

November 2022

Service d'Infectiologie, Hôpital Nord-CHU Saint Etienne, Saint-Etienne, France.

The lifting of non-pharmaceutical measures preventing transmission of SARS-CoV-2 (and other viruses, including influenza viruses) raises concerns about healthcare resources and fears of an increased number of cases of influenza and COVID-19. For the 2021-2022 influenza season, the WHO and >20 European countries promoted coadministration of influenza and COVID-19 vaccines. Recently, the French Health Authority recommended coupling the COVID-19 vaccination with the 2022-2023 influenza vaccination campaign for healthcare professionals and people at risk of severe COVID-19.

View Article and Find Full Text PDF

Prevalence of post-acute coronavirus disease 2019 symptoms twelve months after hospitalization in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.

Clin Microbiol Infect

February 2023

Université Paris Cité, INSERM, IAME UMR 1137, Paris, France; INSERM, Centre d'Investigation clinique 1425, Hôpital Bichat, Paris, France; AP-HP.Nord, Département d'Epidémiologie Biostatistique et Recherche Clinique, Hôpital Bichat, Paris, France. Electronic address:

Article Synopsis
  • A study examined the long-term symptoms of COVID-19 in patients 12 months after hospitalization, finding that 27% experienced three or more persistent symptoms, mainly fatigue, dyspnoea, and joint pain.
  • The research included 737 participants, with a notable difference in outcomes based on gender; women reported more persistent symptoms, anxiety, and depression compared to men.
  • Despite recovery progress, many who were employed before hospitalization still faced challenges, as 27% remained on sick leave at the 12-month mark, highlighting the ongoing impact of COVID-19 on quality of life.
View Article and Find Full Text PDF

In the era of personalized treatment in multiple myeloma, high-risk patients must be accurately identified. The International Myeloma Working Group recommends using the Revised International Staging System (R-ISS) to pick out high-risk patients. The main purpose of our work was to explore the heterogeneity of outcome among R-ISS stage II patients assessing the impact of International Staging System (ISS) stage, chromosomal abnormalities and lactate dehydrogenase level in this subgroup.

View Article and Find Full Text PDF

Lung cancer trends and tumor characteristic changes over 20 years (2000-2020): Results of three French consecutive nationwide prospective cohorts' studies.

Lancet Reg Health Eur

November 2022

Department of Thoracic Oncology, CHU de Lille, CNRS, Inserm, Institut Pasteur de Lille, UMR9020-U1277-CANTHER, Lille, France.

Background: Long-term changes in lung cancer (LC) patients are difficult to evaluate. We report results from the French KBP-2020 real-life cohort.

Methods: KBP-2020 was a prospective cohort that included all patients diagnosed with LC in 2020, in nonacademic public hospital in France.

View Article and Find Full Text PDF

In the last decade, a large number of clinical trials have been deployed using Cardiac Magnetic Resonance (CMR) to evaluate cardioprotective strategies aiming at reducing the irreversible myocardial damage at the time of reperfusion. In these studies, segmentation and quantification of myocardial infarct lesion are often performed with a commercial software or an in-house closed-source code development thus creating a barrier for reproducible research. This paper introduces CMRSegTools: an open-source application software designed for the segmentation and quantification of myocardial infarct lesion enabling full access to state-of-the-art segmentation methods and parameters, easy integration of new algorithms and standardised results sharing.

View Article and Find Full Text PDF
Article Synopsis
  • Older patients with ovarian cancer show a wide range of health statuses, prompting the creation of the geriatric vulnerability score (GVS) to predict treatment outcomes.
  • The EWOC-1 study involved patients 70 and older with stage III or IV ovarian cancer, where those with a GVS of 3 or higher were treated with different chemotherapy regimens and evaluated for survival.
  • Results indicated that higher GVS scores were linked to significantly poorer survival rates, establishing GVS as a critical tool for identifying vulnerable patients in oncological care.
View Article and Find Full Text PDF
Article Synopsis
  • - The EUROPE phase 2 trial examined how well biomarkers predict the effectiveness of romiplostim (ROM) treatment for patients with lower-risk myelodysplastic neoplasms (LR-MDS) and low platelet counts, involving 77 patients from the EMSCO network.
  • - Out of the participants, 42% showed significant improvements in platelet counts, lasting a median of 340 days, while other types of responses (neutrophil and erythroid) were much less common.
  • - The study found that while certain mutations (like SRSF2) and baseline hemoglobin levels were linked to positive responses, ROM treatment did not affect the progression of genetic mutations in patients, confirming its safety and efficacy.
View Article and Find Full Text PDF
Article Synopsis
  • * A total of 133 patients were assessed, and of the 86 who were identified as underdosed, those in the TDM group had higher imatinib levels and a significantly better major molecular response (MMR) at 12 months (67% for TDM vs. 39% for control).
  • * TDM proved to be a feasible approach that not only heightened drug levels but also maintained a positive impact on treatment outcomes for up to three years.
View Article and Find Full Text PDF

Impact of therapeutic drug monitoring of antibiotics in the management of infective endocarditis.

Eur J Clin Microbiol Infect Dis

September 2022

Institut Micalis UMR 1319, Université Paris-Saclay, INRAeChâtenay Malabry, AgroParisTech, France.

Treatment of infective endocarditis (IE) is based on high doses of antibiotics with a prolonged duration. Therapeutic drug monitoring (TDM) allows antibiotic prescription optimization and leads to a personalized medicine, but no study evaluates its interest in the management of IE. We conducted a retrospective, bicentric, descriptive study, from January 2007 to December 2019.

View Article and Find Full Text PDF

Objective: To assess the quality of life (QOL) and describe associated factors in patients with chronic heart failure (HF) living in a low-income population in West Africa.

Methods: This is was a cross-sectional study conducted from January 2017 to June 2018, in the department of cardiology of the University Teaching Hospital (CHU-Campus) in Lomé (Togo). Enrolled patients had stable chronic HF and have been hospitalized in the past 6 months; QOL was assessed using the Minnesota Living with Heart Failure questionnaire (MLHFQ).

View Article and Find Full Text PDF

Time to evaluate decision support systems for antimicrobial prescribing outside the hospital.

Lancet Infect Dis

October 2022

Centre Hospitalier Annecy Genevois, 74370 Epagny Metz-Tessy, France; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, IPLESP, F-75012, Paris, France. Electronic address:

View Article and Find Full Text PDF

Background And Objective: Pediatric cardiomyopathies are clinically heterogeneous heart muscle disorders associated with significant morbidity and mortality for which substantial evidence for a genetic contribution was previously reported. We present a detailed molecular investigation of a cohort of 231 patients presenting with primary cardiomyopathy below the age of 18 years.

Methods: Cases with pediatric cardiomyopathies were analyzed using a next-generation sequencing (NGS) workflow based on a virtual panel including 57 cardiomyopathy-related genes.

View Article and Find Full Text PDF

Objective: To quantify the risk of immune-related adverse events (irAEs) in patients with pre-existing autoimmune disease (pAID) treated by immune checkpoint inhibitors (ICIs) for stage III or IV melanoma.

Methods: Case-control study performed on a French multicentric prospective cohort of patients with melanoma, matched for irAE risk factors and oncological staging. Risk of irAE was assessed by logistic regression.

View Article and Find Full Text PDF

Combination of CDX2 H-score quantitative analysis with CD3 AI-guided analysis identifies patients with a good prognosis only in stage III colon cancer.

Eur J Cancer

September 2022

Centre de Recherche INSERM LNC-UMR1231, F-21000 Dijon, France; University of Burgundy Franche-Comté, F-21000 Dijon, France; Cancer Biology Transfer Platform, Centre Georges-François Leclerc, F-21000 Dijon, France; Genetic and Immunology Medical Institute, Dijon, France; Department of Medical Oncology, Centre Georges-François Leclerc, F-21000 Dijon, France. Electronic address:

Aim: Stratification of colon cancer (CC) of patients with stage II and III for risk of relapse is still needed especially to drive adjuvant therapy administration. Our study evaluates the prognostic performance of two known biomarkers, CDX2 and CD3, standalone or their combined information in stage II and III CC.

Patients And Methods: CDX2 and CD3 expression was evaluated in Prodige-13 study gathering 443 stage II and 398 stage III primary CC on whole slide colectomy.

View Article and Find Full Text PDF

Impact of vaccination on the symptoms of hospitalised patients with SARS-CoV-2 Delta variant (B.1.617.1) infection.

Clin Microbiol Infect

December 2022

Groupe Vaccination-Prévention de La Société de Pathologie Infectieuse de Langue Française (SPILF), France; Department of Internal Medicine and Infectious Diseases, University Hospital of Poitiers; Poitiers, France.

Article Synopsis
  • * A total of 955 patients were analyzed, revealing that vaccinated individuals were older, more male-dominated, and had more health issues, but experienced less severe Covid-19 outcomes compared to unvaccinated patients.
  • * Vaccination significantly reduced the likelihood of requiring intensive care, needing oxygen, and the risk of death, emphasizing its importance in managing severe cases of COVID-19.
View Article and Find Full Text PDF
Article Synopsis
  • Discontinuing tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia (CML) is feasible, but more research is needed on factors that predict recurrence after stopping treatment and the long-term effects of treatment-free remission (TFR).
  • In a study updating data from the STIM2 trial, 199 patients were analyzed, showing a significant percentage (43.4%) achieved TFR at 5 years, but many experienced a loss of major molecular response over time.
  • The timing of molecular recurrence varied, with most recurrences occurring within the first 6 months after stopping treatment, and certain factors such as treatment duration and molecular response levels were linked to recurrence within the first 24 months but not later.
View Article and Find Full Text PDF

Introduction: Today, patients with lung cancer and their relatives can easily search information on the Internet and express themselves online.

Methods: Within this web-ethnographic research, we found, based on 246 search terms related to lung cancer, and collected, a sample of 136 online conversations that were published between January 2004 and September 2018, including 1220 messages by 762 authors.

Results: The authors of messages, many of them close relatives of patients (35%), share their experience (34%).

View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to compare the immune responses of two mRNA COVID-19 vaccines (BNT162b2 and mRNA-1273) to see if mixing them for the second dose produces a similar immune effect as receiving the same vaccine for both doses.
  • - Nearly 400 adults participated, receiving either the same vaccine for both doses or a mix; the results showed that mixing the vaccines resulted in different antibody levels.
  • - Overall, the research suggests that using either vaccine interchangeably is safe and effective, but those who received mRNA-1273 as a second dose reported more side effects compared to those who got BNT162b2.
View Article and Find Full Text PDF

Intensity modulation treatments are widely used in radiotherapy because of many known advantages. In this context, the picket fence test (PF) is a relevant test to check the Multileaf Collimator (MLC) performances. So this work compares and evaluates three analysis platforms for the PF used routinely by three different institutions.

View Article and Find Full Text PDF